LLL-12 for COVID-19

 LLL-12 has been reported as potentially beneficial for COVID-19 in the following studies.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 210+ treatments. We have not reviewed LLL-12 in detail.
Zhu et al., Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening, ACS Pharmacology & Translational Science, doi:10.1021/acsptsci.0c00108
Pang et al., The research progress of SARS-CoV-2 main protease inhibitors from 2020 to 2022, European Journal of Medicinal Chemistry, doi:10.1016/j.ejmech.2023.115491